Taking cues from machine learning, compartmental and time series models for SARS-CoV-2 omicron infection in Indian provinces

被引:0
|
作者
Yadav, Subhash Kumar [1 ]
Khan, Saif Ali [1 ]
Tiwari, Mayank [1 ]
Kumar, Arun [1 ]
Kumar, Vinit [2 ]
Akhter, Yusuf [3 ]
机构
[1] Babasaheb Bhimrao Ambedkar Univ, Sch Phys & Decis Sci, Dept Stat, Lucknow 226025, India
[2] Babasaheb Bhimrao Ambedkar Univ, Sch Informat Sci & Technol, Dept Lib & Informat Sci, Lucknow 226025, India
[3] Babasaheb Bhimrao Ambedkar Univ, Sch Life Sci, Dept Biotechnol, Lucknow 226025, India
关键词
Infectious disease; Disease modeling; Basic reproduction number; Infection rate; Recovery rate; Arima; Random forest; Distribution fitting; SIR EPIDEMIC MODEL; COVID-19; ARIMA; IMMUNITY;
D O I
10.1016/j.sste.2024.100634
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
SARS-CoV-2, the virus responsible for COVID-19, posed a significant threat to the world. We analyzed COVID-19 dissemination data in the top ten Indian provinces by infection incidences using the Susceptible-InfectiousRemoved (SIR) model, an Autoregressive Integrated Moving Average (ARIMA) time series model, a machine learning model based on the Random Forest, and distribution fitting. Outbreaks are expected to continue if the Basic Reproduction Number (R-0 ) > 1, and infection waves are anticipated to end if the R-0 < 1, as determined by the SIR model. Different parametric probability distributions are also fitted. Data collected from December 12, 2021, to March 31, 2022, encompassing data from both before and during the implementation of strict control measures. Based on the estimates of the model parameters, health agencies and government policymakers can develop strategies to combat the spread of the disease in the future, and the most effective technique can be recommended for real-world application for other outbreaks of COVID-19. The best method out of these could be also implemented further on the epidemiological data of other similar infectious agents.
引用
收藏
页数:15
相关论文
共 50 条
  • [41] Innate immune imprints in SARS-CoV-2 Omicron variant infection convalescents
    Zhiqing Li
    Xiaosu Chen
    Junyan Dan
    Tianju Hu
    Ye Hu
    Shuxun Liu
    Yangyang Chai
    Yansong Shi
    Jian Wu
    Hailai Ni
    Jiaqi Zhu
    Yanfeng Wu
    Nan Li
    Yizhi Yu
    Zhongfang Wang
    Jincun Zhao
    Nanshan Zhong
    Xianwen Ren
    Zhongyang Shen
    Xuetao Cao
    Signal Transduction and Targeted Therapy, 7
  • [42] Endoscopic findings of laryngitis caused by SARS-CoV-2/Omicron variant infection
    Yuri Nishiyama
    Koichiro Wasano
    Infection, 2023, 51 : 283 - 284
  • [43] SARS-CoV-2 Omicron infection, who will be developed into severe/critical diseases?
    Mudan Feng
    Qing Lin
    Jian Xu
    Journal of Translational Medicine, 21
  • [44] Antibody Response after SARS-CoV-2 Infection with the Delta and Omicron Variant
    Blaszczuk, Agata
    Michalski, Aleksander
    Sikora, Dominika
    Malm, Maria
    Drop, Bartlomiej
    Polz-Dacewicz, Malgorzata
    VACCINES, 2022, 10 (10)
  • [45] Effectiveness of Bivalent Omicron-Containing Booster Vaccines against SARS-CoV-2 Omicron Variant among Individuals with and without Prior SARS-CoV-2 Infection
    Widyasari, Kristin
    Jang, Jieun
    Kang, Taejoon
    Kim, Sunjoo
    VIRUSES-BASEL, 2023, 15 (08):
  • [46] Severity of SARS-CoV-2 Omicron variant infection in heart transplant recipients
    Hazan, Fanny
    Verdonk, Constance
    Coutance, Guillaume
    Ferre, Valentine Marie
    Marot, Stephane
    Melo, Vania Da Dilva
    Legeai, Camille
    Lebreton, Guillaume
    Para, Marylou
    Varnous, Shaida
    Dorent, Richard
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2023, 42 (05): : 558 - 561
  • [47] Tixagevimab/cilgavimab for Omicron SARS-CoV-2 infection in patients with haematologic diseases
    Armelle Otiniano
    Zoe van de Wyngaert
    Eolia Brissot
    Rémy Dulery
    Joel Gozlan
    Anne Daguenel
    Yasmine Abi Aad
    Laure Ricard
    Nicolas Stocker
    Anne Banet
    Agnes Bonnin
    Tamim Alsuliman
    Zora Marjanovic
    Aurélie Schnuriger
    Paul Coppo
    Ollivier Legrand
    Karine Lacombe
    Mohamad Mohty
    Florent Malard
    Bone Marrow Transplantation, 2023, 58 : 340 - 342
  • [48] Immune responses in Omicron SARS-CoV-2 breakthrough infection in vaccinated adults
    Hassen Kared
    Asia-Sophia Wolf
    Amin Alirezaylavasani
    Anthony Ravussin
    Guri Solum
    Trung The Tran
    Fridtjof Lund-Johansen
    John Torgils Vaage
    Lise Sofie Nissen-Meyer
    Unni C. Nygaard
    Olav Hungnes
    Anna H. Robertson
    Lisbeth Meyer Næss
    Lill Trogstad
    Per Magnus
    Ludvig A. Munthe
    Siri Mjaaland
    Nature Communications, 13
  • [49] Omicron: Understanding the Latest Variant of SARS-CoV-2 and Strategies for Tackling the Infection
    Obireddy, Sreekanth Reddy
    Guntakanti, Ujwala
    Kowthalam, Anitha
    Marata Chinna Subbarao, Subha
    Lai, Wing-Fu
    CHEMBIOCHEM, 2022, 23 (14)
  • [50] Current immunoassays and detection of antibodies elicited by Omicron SARS-CoV-2 infection
    Migueres, Marion
    Chapuy-Regaud, Sabine
    Miedouge, Marcel
    Jamme, Thibaut
    Lougarre, Catherine
    Da Silva, Isabelle
    Pucelle, Melanie
    Staes, Laetitia
    Porcheron, Marion
    Dimeglio, Chloe
    Izopet, Jacques
    JOURNAL OF MEDICAL VIROLOGY, 2023, 95 (01)